Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
PENTOBARBITAL SODIUM
Vetoquinol Ireland Limited
QN51AA01
PENTOBARBITAL SODIUM
200 Mg/Ml
Solution for Injection
VPO-Vet.Practitioner Only
Canine, Feline
Pentobarbital
Neurological Preparations
Authorised
1990-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Dolethal 200 mg/ml Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Solution for injection. A red aqueous solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs, cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Euthanasia of dogs and cats. 4.3 CONTRAINDICATIONS Not for anaesthetic use. Not for use in animals intended for animal or human consumption. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES It may be necessary to increase the dose for older animals weighing more than 10 kg. Each ml contains: Active substance Pentobarbital Sodium 200 mg Excipients Benzyl Alcohol 0.0104 ml Cochineal Red A (E124) 0.01 mg For a full list of excipients, see section 6.1 HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 14/08/2015_ _CRN 7021600_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS None. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO ANIMALS Lethal to humans. Particular care should be taken to avoid accidental exposure to the product. In the case of accidental self-administration (injection, ingestion, skin absorption), seek URGENT medical attention, advising medical services of barbiturate poisoning. In the case of accidental contact with eyes, irrigate eyes immediately with flowing cold or tepid water. In the case of contact with skin, wash immediately with water and then thoroughly with soap and water. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) None. 4.7 USE DURING PREGNANCY, LACTATION OR LAY Not relevant. 4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION None. 4 Read the complete document